Skip to main content
logo
Lupin Limited (BOM:500257)
India flag India · Delayed Price · Currency is INR
2,496.05
-6.85 (-0.27%)
At close: Jul 10, 2026

Lupin Revenue

In the fiscal year ending March 31, 2026, Lupin had annual revenue of 279.58B INR with 23.12% growth. Lupin had revenue of 74.75B in the quarter ending March 31, 2026, with 31.89% growth.

Revenue
279.58B
Revenue Growth
+23.12%
P/S Ratio
4.08
Revenue / Employee
11.65M
Employees
24,006
Market Cap
1.14T

Revenue Chart

Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Mar 31, 2026279.58B52.50B23.12%
Mar 31, 2025227.08B26.97B13.48%
Mar 31, 2024200.11B33.69B20.25%
Mar 31, 2023166.42B2.36B1.44%
Mar 31, 2022164.05B12.43B8.19%
Mar 31, 2021 Pro Pro Pro
Mar 31, 2020 Pro Pro Pro
Mar 31, 2019 Pro Pro Pro
Mar 31, 2018 Pro Pro Pro
Mar 31, 2017 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Dr. Reddy's Laboratories335.93B
Torrent Pharmaceuticals139.80B
Jubilant Pharmova82.80B
Abbott India69.29B
Granules India53.66B
J. B. Chemicals & Pharmaceuticals41.48B
GlaxoSmithKline Pharmaceuticals38.22B
AstraZeneca Pharma India22.76B
Revenue Rankings

Lupin News

More News